MAIER PAUL V

Reported to SECin USFilings at 2 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 15. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 15
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
International Stem Cell CORP—Returned to the issuernothing paid30,000 sharesSep 17, 2026International Stem Cell CORPnothing paidReturned · Sep 17Returned to the issuer30,000Sep 17, 2026
International Stem Cell CORP—Open-market sell$10,49732,802 sharesSep 15, 2026International Stem Cell CORP$10,497Sell · Sep 15Open-market sell32,802Sep 15, 2026
Eton Pharmaceuticals, Inc.—Option exercisenothing paid12,500 sharesAug 31, 2026Eton Pharmaceuticals, Inc.nothing paidExercise · Aug 31Option exercise12,500Aug 31, 2026
Eton Pharmaceuticals, Inc.—Option exercisenothing paid50,000 sharesAug 31, 2026Eton Pharmaceuticals, Inc.nothing paidExercise · Aug 31Option exercise50,000Aug 31, 2026
Eton Pharmaceuticals, Inc.—Option exercise$91,37512,500 sharesAug 31, 2026Eton Pharmaceuticals, Inc.$91,375Exercise · Aug 31Option exercise12,500Aug 31, 2026